Callan Family Office’s Monster Beverage MNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.49M Sell
20,535
-1,327
-6% -$105K 0.03% 441
2025
Q4
$1.68M Buy
21,862
+5,349
+32% +$383K 0.04% 394
2025
Q3
$1.11M Sell
16,513
-389
-2% -$24.3K 0.04% 358
2025
Q2
$1.06M Buy
16,902
+10,378
+159% +$634K 0.03% 386
2025
Q1
$382K Sell
6,524
-146
-2% -$7.61K 0.03% 384
2024
Q4
$351K Buy
+6,670
New +$354K 0.02% 448

Other funds holding MNST

Callan Family Office's MNST Position: Q1 2026 in Review

Callan Family Office reduced its Monster Beverage (MNST) stake by 6.1% in Q1 2026, selling an estimated $105K and leaving 20,535 shares worth $1.49M. The position accounts for 0.03% of the portfolio, ranked #441.

Callan Family Office first reported a position in MNST in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.68M in Q4 2025. 1,236 funds tracked by Wall St. Rank hold MNST as of Q1 2026.

  • Callan Family Office held 20,535 shares of Monster Beverage worth $1.49M as of Q1 2026.
  • Callan Family Office sold 1,327 Monster Beverage shares in Q1 2026, an estimated $105K.
  • Monster Beverage made up 0.03% of Callan Family Office's portfolio in Q1 2026, its #441 holding.
  • Callan Family Office first reported a position in Monster Beverage in Q4 2024 and has held it in 6 quarters since.
  • Callan Family Office's Monster Beverage position peaked at $1.68M in Q4 2025.
  • 1,236 funds tracked by Wall St. Rank held Monster Beverage as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.